CompletedNCT03231800
Dasotraline for ADHD in Children: A Simulated-Classroom Study
About this title
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
Read the official source — NCT03231800Researchers compared dasotraline and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
Medication studyAges 6–12United States
Understand this study
What did researchers investigate?
Researchers compared dasotraline and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
Who was this study for?
Listed age limits: 6 years to 12 years.
- Listed locations
- Newport Beach and 7 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: July 31, 2017
- Recruitment status
- Completed
- Enrollment listed in the registry
- 95
- Sponsor
- Sumitomo Pharma America, Inc.
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 6 Years to 12 Years
- Official registry ID
- NCT03231800
- Official title
Show the full official title
Dasotraline (2mg) in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD): A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Study of Efficacy and Safety in a Laboratory Classroom Setting
Get this study by email
Recruitment & locations
CompletedNewport Beach · Bradenton · Maitland
5 more locations
- South Miami
- Hingham
- Las Vegas
- Houston
- Clinton
Questions about this study
What did researchers investigate?
Researchers compared dasotraline and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
Who is behind this study?
The study sponsor is Sumitomo Pharma America, Inc., a pharmaceutical company.
Did this study involve medication?
Yes. The study involved medication, including dasotraline and Placebo.
Who was this study for?
Listed age limits: 6 years to 12 years.
